TY - JOUR AU - Hampel, H. AU - O'Bryant, S. E. AU - Molinuevo, J. L. AU - Zetterberg, H. AU - Masters, C. L. AU - Lista, S. PY - 2018 DA - 2018// TI - Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic JO - Nat Rev Neurol VL - 14 UR - https://doi.org/10.1038/s41582-018-0079-7 DO - 10.1038/s41582-018-0079-7 ID - Hampel2018 ER - TY - JOUR AU - Nakamura, A. AU - Kaneko, N. AU - Villemagne, V. L. AU - Kato, T. AU - Doecke, J. AU - Dore, V. PY - 2018 DA - 2018// TI - High performance plasma amyloid-beta biomarkers for Alzheimer’s disease JO - Nature. VL - 554 UR - https://doi.org/10.1038/nature25456 DO - 10.1038/nature25456 ID - Nakamura2018 ER - TY - JOUR AU - Janelidze, S. AU - Stomrud, E. AU - Palmqvist, S. AU - Zetterberg, H. AU - Westen, D. AU - Jeromin, A. PY - 2016 DA - 2016// TI - Plasma beta-amyloid in Alzheimer’s disease and vascular disease JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep26801 DO - 10.1038/srep26801 ID - Janelidze2016 ER - TY - JOUR AU - Ovod, V. AU - Ramsey, K. N. AU - Mawuenyega, K. G. AU - Bollinger, J. G. AU - Hicks, T. AU - Schneider, T. PY - 2017 DA - 2017// TI - Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2017.06.2266 DO - 10.1016/j.jalz.2017.06.2266 ID - Ovod2017 ER - TY - JOUR AU - Mattsson, N. i. k. l. a. s. AU - Andreasson, U. l. f. AU - Zetterberg, H. e. n. r. i. k. AU - Blennow, K. a. j. PY - 2017 DA - 2017// TI - Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease JO - JAMA Neurology VL - 74 UR - https://doi.org/10.1001/jamaneurol.2016.6117 DO - 10.1001/jamaneurol.2016.6117 ID - Mattsson2017 ER - TY - JOUR AU - Lewczuk, P. AU - Ermann, N. AU - Andreasson, U. AU - Schultheis, C. AU - Podhorna, J. AU - Spitzer, P. PY - 2018 DA - 2018// TI - Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease JO - Alzheimers Res Ther VL - 10 UR - https://doi.org/10.1186/s13195-018-0404-9 DO - 10.1186/s13195-018-0404-9 ID - Lewczuk2018 ER - TY - JOUR AU - Ashton, N. J. AU - Leuzy, A. AU - Lim, Y. M. AU - Troakes, C. AU - Hortobagyi, T. AU - Hoglund, K. PY - 2019 DA - 2019// TI - Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration JO - Acta Neuropathol Commun VL - 7 UR - https://doi.org/10.1186/s40478-018-0649-3 DO - 10.1186/s40478-018-0649-3 ID - Ashton2019 ER - TY - JOUR AU - Olsson, B. AU - Lautner, R. AU - Andreasson, U. AU - Ohrfelt, A. AU - Portelius, E. AU - Bjerke, M. PY - 2016 DA - 2016// TI - CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis JO - Lancet Neurol VL - 15 UR - https://doi.org/10.1016/S1474-4422(16)00070-3 DO - 10.1016/S1474-4422(16)00070-3 ID - Olsson2016 ER - TY - JOUR AU - Gaetani, L. o. r. e. n. z. o. AU - Blennow, K. a. j. AU - Calabresi, P. a. o. l. o. AU - Di Filippo, M. a. s. s. i. m. i. l. i. a. n. o. AU - Parnetti, L. u. c. i. l. l. a. AU - Zetterberg, H. e. n. r. i. k. PY - 2019 DA - 2019// TI - Neurofilament light chain as a biomarker in neurological disorders JO - Journal of Neurology, Neurosurgery & Psychiatry VL - 90 UR - https://doi.org/10.1136/jnnp-2018-320106 DO - 10.1136/jnnp-2018-320106 ID - Gaetani2019 ER - TY - JOUR AU - Hansson, O. AU - Janelidze, S. AU - Hall, S. AU - Magdalinou, N. AU - Lees, A. J. AU - Andreasson, U. PY - 2017 DA - 2017// TI - Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder JO - Neurology. VL - 88 UR - https://doi.org/10.1212/WNL.0000000000003680 DO - 10.1212/WNL.0000000000003680 ID - Hansson2017 ER - TY - JOUR AU - Rohrer, J. D. AU - Woollacott, I. O. AU - Dick, K. M. AU - Brotherhood, E. AU - Gordon, E. AU - Fellows, A. PY - 2016 DA - 2016// TI - Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia JO - Neurology. VL - 87 UR - https://doi.org/10.1212/WNL.0000000000003154 DO - 10.1212/WNL.0000000000003154 ID - Rohrer2016 ER - TY - JOUR AU - Byrne, L. M. AU - Rodrigues, F. B. AU - Blennow, K. AU - Durr, A. AU - Leavitt, B. R. AU - Roos, R. A. C. PY - 2017 DA - 2017// TI - Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis JO - Lancet Neurol VL - 16 UR - https://doi.org/10.1016/S1474-4422(17)30124-2 DO - 10.1016/S1474-4422(17)30124-2 ID - Byrne2017 ER - TY - JOUR AU - Mattsson, N. AU - Zetterberg, H. AU - Janelidze, S. AU - Insel, P. S. AU - Andreasson, U. AU - Stomrud, E. PY - 2016 DA - 2016// TI - Plasma tau in Alzheimer disease JO - Neurology. VL - 87 UR - https://doi.org/10.1212/WNL.0000000000003246 DO - 10.1212/WNL.0000000000003246 ID - Mattsson2016 ER - TY - JOUR AU - Mielke, M. M. AU - Hagen, C. E. AU - Xu, J. AU - Chai, X. AU - Vemuri, P. AU - Lowe, V. J. PY - 2018 DA - 2018// TI - Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau- and amyloid-positron emission tomography JO - Alzheimers Dement VL - 14 UR - https://doi.org/10.1016/j.jalz.2018.02.013 DO - 10.1016/j.jalz.2018.02.013 ID - Mielke2018 ER - TY - JOUR AU - Foulds, P. AU - McAuley, E. AU - Gibbons, L. AU - Davidson, Y. AU - Pickering-Brown, S. M. AU - Neary, D. PY - 2008 DA - 2008// TI - TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration JO - Acta Neuropathol VL - 116 UR - https://doi.org/10.1007/s00401-008-0389-8 DO - 10.1007/s00401-008-0389-8 ID - Foulds2008 ER - TY - JOUR AU - Barbour, R. AU - Kling, K. AU - Anderson, J. P. AU - Banducci, K. AU - Cole, T. AU - Diep, L. PY - 2008 DA - 2008// TI - Red blood cells are the major source of alpha-synuclein in blood JO - Neurodegener Dis VL - 5 UR - https://doi.org/10.1159/000112832 DO - 10.1159/000112832 ID - Barbour2008 ER - TY - JOUR AU - Kvartsberg, H. AU - Portelius, E. AU - Andreasson, U. AU - Brinkmalm, G. AU - Hellwig, K. AU - Lelental, N. PY - 2015 DA - 2015// TI - Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls JO - Alzheimers Res Ther VL - 7 UR - https://doi.org/10.1186/s13195-015-0124-3 DO - 10.1186/s13195-015-0124-3 ID - Kvartsberg2015 ER - TY - JOUR AU - Guerreiro, R. AU - Wojtas, A. AU - Bras, J. AU - Carrasquillo, M. AU - Rogaeva, E. AU - Majounie, E. PY - 2013 DA - 2013// TI - TREM2 variants in Alzheimer’s disease JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1211851 DO - 10.1056/NEJMoa1211851 ID - Guerreiro2013 ER - TY - JOUR AU - Jonsson, T. AU - Stefansson, H. AU - Steinberg, S. AU - Jonsdottir, I. AU - Jonsson, P. V. AU - Snaedal, J. PY - 2013 DA - 2013// TI - Variant of TREM2 associated with the risk of Alzheimer’s disease JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1211103 DO - 10.1056/NEJMoa1211103 ID - Jonsson2013 ER - TY - JOUR AU - Cuyvers, E. AU - Bettens, K. AU - Philtjens, S. AU - Langenhove, T. AU - Gijselinck, I. AU - Zee, J. PY - 2014 DA - 2014// TI - Investigating the role of rare heterozygous TREM2 variants in Alzheimer’s disease and frontotemporal dementia JO - Neurobiol Aging VL - 35 UR - https://doi.org/10.1016/j.neurobiolaging.2013.09.009 DO - 10.1016/j.neurobiolaging.2013.09.009 ID - Cuyvers2014 ER - TY - JOUR AU - Borroni, B. AU - Ferrari, F. AU - Galimberti, D. AU - Nacmias, B. AU - Barone, C. AU - Bagnoli, S. PY - 2014 DA - 2014// TI - Heterozygous TREM2 mutations in frontotemporal dementia JO - Neurobiol Aging VL - 35 UR - https://doi.org/10.1016/j.neurobiolaging.2013.09.017 DO - 10.1016/j.neurobiolaging.2013.09.017 ID - Borroni2014 ER - TY - JOUR AU - Rayaprolu, S. AU - Mullen, B. AU - Baker, M. AU - Lynch, T. AU - Finger, E. AU - Seeley, W. W. PY - 2013 DA - 2013// TI - TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease JO - Mol Neurodegener VL - 8 UR - https://doi.org/10.1186/1750-1326-8-19 DO - 10.1186/1750-1326-8-19 ID - Rayaprolu2013 ER - TY - JOUR AU - Cady, J. AU - Koval, E. D. AU - Benitez, B. A. AU - Zaidman, C. AU - Jockel-Balsarotti, J. AU - Allred, P. PY - 2014 DA - 2014// TI - TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis JO - JAMA Neurol VL - 71 UR - https://doi.org/10.1001/jamaneurol.2013.6237 DO - 10.1001/jamaneurol.2013.6237 ID - Cady2014 ER - TY - JOUR AU - Wunderlich, P. AU - Glebov, K. AU - Kemmerling, N. AU - Tien, N. T. AU - Neumann, H. AU - Walter, J. PY - 2013 DA - 2013// TI - Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage JO - J Biol Chem VL - 288 UR - https://doi.org/10.1074/jbc.M113.517540 DO - 10.1074/jbc.M113.517540 ID - Wunderlich2013 ER - TY - JOUR AU - Feuerbach, D. AU - Schindler, P. AU - Barske, C. AU - Joller, S. AU - Beng-Louka, E. AU - Worringer, K. A. PY - 2017 DA - 2017// TI - ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157 JO - Neurosci Lett VL - 660 UR - https://doi.org/10.1016/j.neulet.2017.09.034 DO - 10.1016/j.neulet.2017.09.034 ID - Feuerbach2017 ER - TY - JOUR AU - Schlepckow, K. AU - Kleinberger, G. AU - Fukumori, A. AU - Feederle, R. AU - Lichtenthaler, S. F. AU - Steiner, H. PY - 2017 DA - 2017// TI - An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function JO - EMBO Mol Med. VL - 9 UR - https://doi.org/10.15252/emmm.201707672 DO - 10.15252/emmm.201707672 ID - Schlepckow2017 ER - TY - JOUR AU - Thornton, P. AU - Sevalle, J. AU - Deery, M. J. AU - Fraser, G. AU - Zhou, Y. AU - Stahl, S. PY - 2017 DA - 2017// TI - TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer’s disease-associated H157Y variant JO - EMBO Mol Med VL - 9 UR - https://doi.org/10.15252/emmm.201707673 DO - 10.15252/emmm.201707673 ID - Thornton2017 ER - TY - JOUR AU - Piccio, L. AU - Buonsanti, C. AU - Cella, M. AU - Tassi, I. AU - Schmidt, R. E. AU - Fenoglio, C. PY - 2008 DA - 2008// TI - Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation JO - Brain. VL - 131 UR - https://doi.org/10.1093/brain/awn217 DO - 10.1093/brain/awn217 ID - Piccio2008 ER - TY - JOUR AU - Kleinberger, G. AU - Yamanishi, Y. AU - Suarez-Calvet, M. AU - Czirr, E. AU - Lohmann, E. AU - Cuyvers, E. PY - 2014 DA - 2014// TI - TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3009093 DO - 10.1126/scitranslmed.3009093 ID - Kleinberger2014 ER - TY - JOUR AU - Suarez-Calvet, M. AU - Kleinberger, G. AU - Araque Caballero, M. A. AU - Brendel, M. AU - Rominger, A. AU - Alcolea, D. PY - 2016 DA - 2016// TI - sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers JO - EMBO Mol Med. VL - 8 UR - https://doi.org/10.15252/emmm.201506123 DO - 10.15252/emmm.201506123 ID - Suarez-Calvet2016 ER - TY - JOUR AU - Heslegrave, A. AU - Heywood, W. AU - Paterson, R. AU - Magdalinou, N. AU - Svensson, J. AU - Johansson, P. PY - 2016 DA - 2016// TI - Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease JO - Mol Neurodegener VL - 11 UR - https://doi.org/10.1186/s13024-016-0071-x DO - 10.1186/s13024-016-0071-x ID - Heslegrave2016 ER - TY - JOUR AU - Piccio, L. AU - Deming, Y. AU - Del-Aguila, J. L. AU - Ghezzi, L. AU - Holtzman, D. M. AU - Fagan, A. M. PY - 2016 DA - 2016// TI - Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status JO - Acta Neuropathol VL - 131 UR - https://doi.org/10.1007/s00401-016-1533-5 DO - 10.1007/s00401-016-1533-5 ID - Piccio2016 ER - TY - JOUR AU - Suarez-Calvet, M. AU - Morenas-Rodriguez, E. AU - Kleinberger, G. AU - Schlepckow, K. AU - Araque Caballero, M. A. AU - Franzmeier, N. PY - 2019 DA - 2019// TI - Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-beta pathology JO - Mol Neurodegener VL - 14 UR - https://doi.org/10.1186/s13024-018-0301-5 DO - 10.1186/s13024-018-0301-5 ID - Suarez-Calvet2019 ER - TY - STD TI - Rauchmann BS, Schneider-Axmann T, Alexopoulos P, Perneczky R, Alzheimer’s Disease Neuroimaging I. CSF soluble TREM2 as a measure of immune response along the Alzheimer’s disease continuum. Neurobiol Aging 2019;74:182–190. ID - ref34 ER - TY - JOUR AU - Suarez-Calvet, M. AU - Araque Caballero, M. A. AU - Kleinberger, G. AU - Bateman, R. J. AU - Fagan, A. M. AU - Morris, J. C. PY - 2016 DA - 2016// TI - Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aag1767 DO - 10.1126/scitranslmed.aag1767 ID - Suarez-Calvet2016 ER - TY - JOUR AU - Lovestone, S. AU - Francis, P. AU - Kloszewska, I. AU - Mecocci, P. AU - Simmons, A. AU - Soininen, H. PY - 2009 DA - 2009// TI - AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer’s disease JO - Ann N Y Acad Sci VL - 1180 UR - https://doi.org/10.1111/j.1749-6632.2009.05064.x DO - 10.1111/j.1749-6632.2009.05064.x ID - Lovestone2009 ER - TY - JOUR AU - Hye, A. AU - Riddoch-Contreras, J. AU - Baird, A. L. AU - Ashton, N. J. AU - Bazenet, C. AU - Leung, R. PY - 2014 DA - 2014// TI - Plasma proteins predict conversion to dementia from prodromal disease JO - Alzheimers Dement VL - 10 UR - https://doi.org/10.1016/j.jalz.2014.05.1749 DO - 10.1016/j.jalz.2014.05.1749 ID - Hye2014 ER - TY - JOUR AU - Hye, A. AU - Lynham, S. AU - Thambisetty, M. AU - Causevic, M. AU - Campbell, J. AU - Byers, H. L. PY - 2006 DA - 2006// TI - Proteome-based plasma biomarkers for Alzheimer’s disease JO - Brain. VL - 129 UR - https://doi.org/10.1093/brain/awl279 DO - 10.1093/brain/awl279 ID - Hye2006 ER - TY - JOUR AU - Ruiz, A. AU - Dols-Icardo, O. AU - Bullido, M. J. AU - Pastor, P. AU - Rodriguez-Rodriguez, E. AU - Lopez de Munain, A. PY - 2014 DA - 2014// TI - Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer’s disease and frontotemporal dementia JO - Neurobiol Aging VL - 35 UR - https://doi.org/10.1016/j.neurobiolaging.2013.08.011 DO - 10.1016/j.neurobiolaging.2013.08.011 ID - Ruiz2014 ER - TY - JOUR AU - Benitez, B. A. AU - Cooper, B. AU - Pastor, P. AU - Jin, S. C. AU - Lorenzo, E. AU - Cervantes, S. PY - 2013 DA - 2013// TI - TREM2 is associated with the risk of Alzheimer’s disease in Spanish population JO - Neurobiol Aging VL - 34 UR - https://doi.org/10.1016/j.neurobiolaging.2012.12.018 DO - 10.1016/j.neurobiolaging.2012.12.018 ID - Benitez2013 ER - TY - JOUR AU - Reijs, B. L. R. AU - Ramakers, I. AU - Elias-Sonnenschein, L. AU - Teunissen, C. E. AU - Koel-Simmelink, M. AU - Tsolaki, M. PY - 2017 DA - 2017// TI - Relation of odor identification with Alzheimer’s disease markers in cerebrospinal fluid and cognition JO - J Alzheimers Dis VL - 60 UR - https://doi.org/10.3233/JAD-170564 DO - 10.3233/JAD-170564 ID - Reijs2017 ER - TY - JOUR AU - Ohara, T. AU - Hata, J. AU - Tanaka, M. AU - Honda, T. AU - Yamakage, H. AU - Yoshida, D. PY - 2019 DA - 2019// TI - Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the Hisayama study JO - Ann Neurol VL - 85 UR - https://doi.org/10.1002/ana.25385 DO - 10.1002/ana.25385 ID - Ohara2019 ER - TY - JOUR AU - Bouchon, A. AU - Hernandez-Munain, C. AU - Cella, M. AU - Colonna, M. PY - 2001 DA - 2001// TI - A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells JO - J Exp Med VL - 194 UR - https://doi.org/10.1084/jem.194.8.1111 DO - 10.1084/jem.194.8.1111 ID - Bouchon2001 ER - TY - JOUR AU - Schmid, C. D. AU - Sautkulis, L. N. AU - Danielson, P. E. AU - Cooper, J. AU - Hasel, K. W. AU - Hilbush, B. S. PY - 2002 DA - 2002// TI - Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia JO - J Neurochem VL - 83 UR - https://doi.org/10.1046/j.1471-4159.2002.01243.x DO - 10.1046/j.1471-4159.2002.01243.x ID - Schmid2002 ER - TY - JOUR AU - Paloneva, J. AU - Mandelin, J. AU - Kiialainen, A. AU - Bohling, T. AU - Prudlo, J. AU - Hakola, P. PY - 2003 DA - 2003// TI - DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features JO - J Exp Med VL - 198 UR - https://doi.org/10.1084/jem.20030027 DO - 10.1084/jem.20030027 ID - Paloneva2003 ER - TY - JOUR AU - Kiialainen, A. AU - Hovanes, K. AU - Paloneva, J. AU - Kopra, O. AU - Peltonen, L. PY - 2005 DA - 2005// TI - Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS JO - Neurobiol Dis VL - 18 UR - https://doi.org/10.1016/j.nbd.2004.09.007 DO - 10.1016/j.nbd.2004.09.007 ID - Kiialainen2005 ER - TY - JOUR AU - Paloneva, J. AU - Manninen, T. AU - Christman, G. AU - Hovanes, K. AU - Mandelin, J. AU - Adolfsson, R. PY - 2002 DA - 2002// TI - Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype JO - Am J Hum Genet VL - 71 UR - https://doi.org/10.1086/342259 DO - 10.1086/342259 ID - Paloneva2002 ER - TY - JOUR AU - Guerreiro, R. AU - Bilgic, B. AU - Guven, G. AU - Bras, J. AU - Rohrer, J. AU - Lohmann, E. PY - 2013 DA - 2013// TI - Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family JO - Neurobiol Aging VL - 34 UR - https://doi.org/10.1016/j.neurobiolaging.2013.06.005 DO - 10.1016/j.neurobiolaging.2013.06.005 ID - Guerreiro2013 ER - TY - JOUR AU - Kleinberger, G. AU - Brendel, M. AU - Mracsko, E. AU - Wefers, B. AU - Groeneweg, L. AU - Xiang, X. PY - 2017 DA - 2017// TI - The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism JO - EMBO J VL - 36 UR - https://doi.org/10.15252/embj.201796516 DO - 10.15252/embj.201796516 ID - Kleinberger2017 ER - TY - JOUR AU - Park, J. S. AU - Ji, I. J. AU - An, H. J. AU - Kang, M. J. AU - Kang, S. W. AU - Kim, D. H. PY - 2015 DA - 2015// TI - Disease-associated mutations of TREM2 alter the processing of N-linked oligosaccharides in the golgi apparatus JO - Traffic. VL - 16 UR - https://doi.org/10.1111/tra.12264 DO - 10.1111/tra.12264 ID - Park2015 ER - TY - JOUR AU - Jiang, T. AU - Tan, L. AU - Chen, Q. AU - Tan, M. S. AU - Zhou, J. S. AU - Zhu, X. C. PY - 2016 DA - 2016// TI - A rare coding variant in TREM2 increases risk for Alzheimer’s disease in Han Chinese JO - Neurobiol Aging VL - 42 UR - https://doi.org/10.1016/j.neurobiolaging.2016.02.029 DO - 10.1016/j.neurobiolaging.2016.02.029 ID - Jiang2016 ER - TY - STD TI - Kober DL, Alexander-Brett JM, Karch CM, Cruchaga C, Colonna M, Holtzman MJ, et al. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife. 2016;5:e20391. ID - ref52 ER - TY - JOUR AU - Song, W. AU - Hooli, B. AU - Mullin, K. AU - Jin, S. C. AU - Cella, M. AU - Ulland, T. K. PY - 2017 DA - 2017// TI - Alzheimer’s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2016.07.004 DO - 10.1016/j.jalz.2016.07.004 ID - Song2017 ER - TY - JOUR AU - Sudom, A. AU - Talreja, S. AU - Danao, J. AU - Bragg, E. AU - Kegel, R. AU - Min, X. PY - 2018 DA - 2018// TI - Molecular basis for the loss-of-function effects of the Alzheimer’s disease-associated R47H variant of the immune receptor TREM2 JO - J Biol Chem VL - 293 UR - https://doi.org/10.1074/jbc.RA118.002352 DO - 10.1074/jbc.RA118.002352 ID - Sudom2018 ER - TY - JOUR AU - Slattery, C. F. AU - Beck, J. A. AU - Harper, L. AU - Adamson, G. AU - Abdi, Z. AU - Uphill, J. PY - 2014 DA - 2014// TI - R47H TREM2 variant increases risk of typical early-onset Alzheimer’s disease but not of prion or frontotemporal dementia JO - Alzheimers Dement VL - 10 UR - https://doi.org/10.1016/j.jalz.2014.05.1751 DO - 10.1016/j.jalz.2014.05.1751 ID - Slattery2014 ER - TY - JOUR AU - Gispert, J. D. AU - Suarez-Calvet, M. AU - Monte, G. C. AU - Tucholka, A. AU - Falcon, C. AU - Rojas, S. PY - 2016 DA - 2016// TI - Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer’s disease JO - Alzheimers Dement VL - 12 UR - https://doi.org/10.1016/j.jalz.2016.06.005 DO - 10.1016/j.jalz.2016.06.005 ID - Gispert2016 ER -